XML 17 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
9 Months Ended
Aug. 31, 2011
Aug. 31, 2010
Cash flows from operating activities:    
Net income (loss) $ (192,679) $ (86,810)
Adjustments to reconcile net loss to net cash used by operating activities:    
Equity in (income) loss of unconsolidated joint ventures 56,241 (1,267)
Distributions of earnings from unconsolidated joint ventures 6,312 10,000
Loss on loan guaranty 37,330 0
Gain on sale of operating property (8,825) 0
Amortization of discounts and issuance costs 1,660 1,605
Depreciation and amortization 1,636 2,628
(Gain) on early extinguishment of debt/loss on voluntary termination of revolving credit facility (3,612) 1,802
Tax benefits from stock-based compensation 0 1,599
Stock-based compensation expense 5,765 5,975
Inventory impairments and land option contract abandonments 23,507 16,739
Change in assets and liabilities:    
Receivables (10,940) 182,762
Inventories (177,770) (149,021)
Accounts payable, accrued expenses and other liabilities (46,953) (147,323)
Other, net (1,611) (2,832)
Net cash used by operating activities (309,939) (164,143)
Cash flows from investing activities:    
Investments in unconsolidated joint ventures (1,974) (1,533)
Proceeds from sale of operating property 80,600 0
Purchases of property and equipment, net (74) (642)
Net cash provided (used) by investing activities 78,552 (2,175)
Cash flows from financing activities:    
Change in restricted cash 2,291 (2,092)
Repayment of senior notes (100,000) 0
Payments on mortgages and land contracts due to land sellers and other loans (86,064) (73,371)
Issuance of common stock under employee stock plans 1,426 1,609
Excess tax benefit associated with exercise of stock options 0 583
Payments of cash dividends (14,423) (14,415)
Repurchases of common stock 0 (350)
Net cash used by financing activities (196,770) (88,036)
Net decrease in cash and cash equivalents (428,157) (254,354)
Cash and cash equivalents at beginning of period 908,430 1,177,961
Cash and cash equivalents at end of period $ 480,273 $ 923,607